Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D MacIntyre

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|June 19, 1993
Sumatriptan and chest painW S Hillis, P D MacIntyre
British Journal of Sports Medicine|August 23, 2000
Potentially reversible causes of non-ventricular fibrillation/ventricular tachycardia (VF/VT)P D MacIntyre, E L Lloyd
Lancet (London, England)|September 11, 1993
Sumatriptan and chest painW S Hillis, P D Macintyre
Lancet (London, England)|November 26, 1994
Sumatriptan-induced chest painS Hood, D Birnie, P D MacIntyre, et al.
International Journal of Cardiology|January 31, 1997
Blind atrial pacing for patients with sinus node disease who develop atrial fibrillation during permanent pacemaker implantationT Fyfe, P D MacIntyre, J F Robinson, et al.
British Journal of Clinical Pharmacology|October 6, 1999
Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptanS Hood, D Birnie, L S Murray, et al.
British Journal of Clinical Pharmacology|December 1, 1992
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulationP D Macintyre, B Bhargava, K J Hogg, et al.
Circulation|February 1, 1993
Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulationP D MacIntyre, B Bhargava, K J Hogg, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 13, 2001
A randomized, controlled trial to study the effect of exercise consultation on the promotion of physical activity in people with Type 2 diabetes: a pilot studyA F Kirk, L A Higgins, A R Hughes, et al.
Clinical Science (London, England : 1979)|May 18, 2000
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?G P McCann, H Cahill, S Knipe, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|June 19, 1993
Sumatriptan and chest painW S Hillis, P D MacIntyre
British Journal of Sports Medicine|August 23, 2000
Potentially reversible causes of non-ventricular fibrillation/ventricular tachycardia (VF/VT)P D MacIntyre, E L Lloyd
Lancet (London, England)|September 11, 1993
Sumatriptan and chest painW S Hillis, P D Macintyre
Lancet (London, England)|November 26, 1994
Sumatriptan-induced chest painS Hood, D Birnie, P D MacIntyre, et al.
International Journal of Cardiology|January 31, 1997
Blind atrial pacing for patients with sinus node disease who develop atrial fibrillation during permanent pacemaker implantationT Fyfe, P D MacIntyre, J F Robinson, et al.
British Journal of Clinical Pharmacology|October 6, 1999
Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptanS Hood, D Birnie, L S Murray, et al.
British Journal of Clinical Pharmacology|December 1, 1992
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulationP D Macintyre, B Bhargava, K J Hogg, et al.
Circulation|February 1, 1993
Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulationP D MacIntyre, B Bhargava, K J Hogg, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 13, 2001
A randomized, controlled trial to study the effect of exercise consultation on the promotion of physical activity in people with Type 2 diabetes: a pilot studyA F Kirk, L A Higgins, A R Hughes, et al.
Clinical Science (London, England : 1979)|May 18, 2000
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?G P McCann, H Cahill, S Knipe, et al.
Pageof 2